Spencer Pharmaceutical (SPPH)

[$on_myMind]

"The Strategy:
The past few years, the scientific team has been dedicated to prove the concept and has claimed the intellectual property through a registered patent. The therapeutic challenges being the same for all Central Nervous System (CNS) diseases, INSA has created a series of prodrugs able to cross efficiently the Blood Brain Barrier and outclass all the current commercial drugs for CNS diseases. (Alzheimer’s, depression, Schizophrenia, bipolar disorder and brain tumours).